Login / Signup

Second-line tislelizumab versus chemotherapy in Japanese patients with advanced or metastatic esophageal squamous cell carcinoma: subgroup analysis from RATIONALE-302.

Hiroki HaraTaroh SatohTakashi KojimaTakahiro TsushimaYu SunakawaMorihito OkadaNingning DingHongqian WuLiyun LiTian YuGisoo BarnesKen Kato
Published in: Esophagus : official journal of the Japan Esophageal Society (2024)
ClinicalTrials.gov: NCT03430843.
Keyphrases
  • squamous cell carcinoma
  • small cell lung cancer
  • clinical trial
  • locally advanced
  • rectal cancer
  • chemotherapy induced